Latest Manufacturing News

Cardiex Limited reported a $2.94 million cash outflow for Q2 FY2025 but bolstered its balance sheet with a $3.25 million placement. The company has begun delivering its CONNEQT Pulse units, signaling a new revenue stream and ongoing R&D investment.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.

Nutritional Growth Solutions reported a slight revenue decline in Q4 FY24 but remains optimistic about growth and profitability in FY25, buoyed by renewed Walmart partnerships and expanding Asian distribution.

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Range International Limited has appointed Russell Kennett as its new CEO, marking a pivotal step in the company’s growth strategy. The move comes alongside an update to Executive Chairman Richard Jenkins’ remuneration, underscoring leadership continuity.

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.

GWR Group Limited reports completion of phase two drilling at its Prospect Ridge Magnesium Project with assay results pending, while divesting its Hatches Creek interest to bolster focus and capital for growth.

Provaris Energy has achieved a major breakthrough with a term sheet for green hydrogen supply to Uniper, marking Europe's first large-scale regional hydrogen marine transport project. Concurrently, the company is advancing innovative CO2 tank designs in partnership with Yinson, positioning itself at the forefront of energy transition infrastructure.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Talga Group has achieved critical milestones with environmental permits and a 25-year mining concession for its Nunasvaara South graphite mine, alongside securing a €70 million EU Innovation Fund grant for its Luleå Anode Refinery, positioning it at the forefront of Europe's battery materials supply chain.